オレゴンにおける急性リンパ性白血病の臨床試験
オレゴン内の拠点で、急性リンパ性白血病に関する10件の研究が参加者を募集しています。
オレゴン内の都市
公式研究テキスト（英語）
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Oregon Health & Science University, Portland
被験者募集中第1/2相
30 Days · 全性別 · 2026/09/16更新 · NCT04065399Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- 他8件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/09/02更新 · NCT05334069The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
被験者募集中第1/2相
22歳以下 · 全性別 · 2026/08/25更新 · NCT04726241Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Oregon Health & Science University, Portland
被験者募集中第2相
7歳〜25歳 · 全性別 · 2026/08/19更新 · NCT05082519A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Oregon Health & Science University/Doernbecher Children's Hospital, Portland
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Doernbecher Children's Hospital, Portland
被験者募集中第1/2相
1歳以下 · 全性別 · 2026/06/03更新 · NCT05848687Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
被験者募集中観察研究
全年齢 · 全性別 · 2026/05/18更新 · NCT01790152A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Oncology Associates of Oregon, Eugene
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/03/24更新 · NCT04988555A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Oregon Health & Science University, Portland
被験者募集中第2相
18歳〜66歳 · 全性別 · 2026/03/17更新 · NCT06859424Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Oregon Health & Science University, Portland
被験者募集中第1相
1歳〜21歳 · 全性別 · 2024/12/06更新 · NCT05476770ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。